Matches in Nanopublications for { ?s ?p "[To investigate catecholamine phenotypes and the effects of a tyrosine hydroxylase inhibitor in individuals with the 22q11.2 deletion syndrome and low-activity catechol-O-methyltransferase (COMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217299.RAiNz3lRo5W-0EfcWAEESkKrPIIYI2oqaZSBTBu46YEu0130_assertion description "[To investigate catecholamine phenotypes and the effects of a tyrosine hydroxylase inhibitor in individuals with the 22q11.2 deletion syndrome and low-activity catechol-O-methyltransferase (COMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217299.RAiNz3lRo5W-0EfcWAEESkKrPIIYI2oqaZSBTBu46YEu0130_provenance.
- NP884305.RA7aNiJKsE_KxaRdvphTw7KJ3LfhCzPwCu9RZhfHJhVEM130_assertion description "[To investigate catecholamine phenotypes and the effects of a tyrosine hydroxylase inhibitor in individuals with the 22q11.2 deletion syndrome and low-activity catechol-O-methyltransferase (COMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP884305.RA7aNiJKsE_KxaRdvphTw7KJ3LfhCzPwCu9RZhfHJhVEM130_provenance.
- NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_assertion description "[To investigate catecholamine phenotypes and the effects of a tyrosine hydroxylase inhibitor in individuals with the 22q11.2 deletion syndrome and low-activity catechol-O-methyltransferase (COMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_provenance.
- NP327047.RAQkDGx-i3sGgef6AB7uNVFPkvTJsJa2GFByx0vsjgfNg130_assertion description "[To investigate catecholamine phenotypes and the effects of a tyrosine hydroxylase inhibitor in individuals with the 22q11.2 deletion syndrome and low-activity catechol-O-methyltransferase (COMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP327047.RAQkDGx-i3sGgef6AB7uNVFPkvTJsJa2GFByx0vsjgfNg130_provenance.
- NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_assertion description "[To investigate catecholamine phenotypes and the effects of a tyrosine hydroxylase inhibitor in individuals with the 22q11.2 deletion syndrome and low-activity catechol-O-methyltransferase (COMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735354.RAlxBxymkh8a5MqUFWPMlVJ8l9Otz4Dweqi8R-wdAFMZs130_provenance.
- NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_assertion description "[To investigate catecholamine phenotypes and the effects of a tyrosine hydroxylase inhibitor in individuals with the 22q11.2 deletion syndrome and low-activity catechol-O-methyltransferase (COMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP327049.RAp97ZbBK3jAZF0DFeH_U6vq_yt0ZkbKSpOYMQ1gANZJ4130_provenance.